puromycin aminonucleoside has been researched along with Elevated Cholesterol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DUBACH, UC; HATCH, E; KOCH, M; RECANT, L | 1 |
| Castañeda-Hernández, G; Medeiros, M; Muñoz-Arizpe, R; Pedraza-Chaverri, J; Pérez-Urizar, J | 1 |
| Correa-Rotter, R; Cruz, C; Juárez-Nicolás, F; Pedraza-Chaverrí, J; Tapia, E | 1 |
| Diamond, JR; Ding, G; Frye, J; van Goor, H | 1 |
| Diamond, JR; Ding, G; Pesek-Diamond, I | 1 |
| Chung, HK; Jeong, JY; Kim, BC; Kim, YS; Lee, HS; Zhang, YZ | 1 |
| al-Shurbaji, A; Berglund, L; Humble, E; Lindenthal, B; Rudling, M | 1 |
| Hoyer, JR; Mauer, SM; Michael, AF | 1 |
| Freeman, RM; Rames, LK; Richards, CJ | 1 |
| Drummond, KN; Kaplan, BS; Renaud, L | 1 |
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
| Diamond, JR; Hanchak, NA; Karnovsky, MJ; McCarter, MD | 1 |
12 other study(ies) available for puromycin aminonucleoside and Elevated Cholesterol
| Article | Year |
|---|---|
Sequence of development of hypercholesterolemia and hypoproteinemia in aminonucleoside nephrosis.
Topics: Cholesterol; Hypercholesterolemia; Hypoproteinemia; Nephrosis; Nucleosides; Nucleotides; Puromycin Aminonucleoside | 1960 |
Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
Topics: Animals; Area Under Curve; Biological Availability; Cholesterol; Cyclosporine; Disease Models, Animal; Half-Life; Hypercholesterolemia; Hypertriglyceridemia; Hypoalbuminemia; Immunosuppressive Agents; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Wistar | 2007 |
Abnormalities of coagulation in experimental nephrotic syndrome.
Topics: Albuminuria; alpha-2-Antiplasmin; Animals; Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinolysis; Hypercholesterolemia; Male; Nephrotic Syndrome; Partial Thromboplastin Time; Polyuria; Proteinuria; Prothrombin Time; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1994 |
Transforming growth factor-beta expression in macrophages during hypercholesterolemic states.
Topics: Albuminuria; Animals; Base Sequence; Cholesterol, Dietary; Gene Expression; Hypercholesterolemia; Immunohistochemistry; Kidney Glomerulus; Lipids; Macrophages; Male; Molecular Sequence Data; Nephrosis; Polymerase Chain Reaction; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 1994 |
Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis.
Topics: Albuminuria; Animals; Cholesterol; Cholic Acids; Extracellular Matrix; Fibronectins; Food, Fortified; Gene Expression; Hypercholesterolemia; Immunohistochemistry; Kidney Glomerulus; Lipids; Macrophages; Male; Nephrosis; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Up-Regulation | 1993 |
Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Cholesterol, Dietary; Diet; Glomerulosclerosis, Focal Segmental; Hypercholesterolemia; Immunohistochemistry; Kidney; Kidney Cortex; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Oxidation-Reduction; Probucol; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Vitamin E | 1997 |
Hepatic cholesterol metabolism in experimental nephrotic syndrome.
Topics: Animals; Cholesterol; Glomerular Filtration Rate; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Liver; Male; Mevalonic Acid; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, LDL | 1998 |
Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
Topics: Albumins; Albuminuria; Animals; Complement System Proteins; Disease Models, Animal; Fluorescent Antibody Technique; Functional Laterality; Humans; Hypercholesterolemia; Immunoglobulin G; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Male; Nephrectomy; Nephrotic Syndrome; Perfusion; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Lew; Serum Albumin; Sodium Chloride | 1975 |
Zinc metabolism in aminonucleoside-induced nephrosis.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Body Weight; Bone and Bones; Hypercholesterolemia; Kidney; Male; Muscles; Nephrosis; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Serum Albumin; Testis; Zinc | 1975 |
Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli.
Topics: Adenine; Animals; Blood Proteins; Carbon Dioxide; Carbon Radioisotopes; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Antagonism; Glucose; Glutamine; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrotic Syndrome; Oxidation-Reduction; Proteinuria; Puromycin; Puromycin Aminonucleoside; Pyruvates; Rats | 1976 |
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |
Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
Topics: Animals; Cholesterol; Cholestyramine Resin; Diet; Disease Models, Animal; Glomerular Filtration Rate; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1990 |